Skip Navigation LinksIntegrated Review Groups > Population Sciences and Epidemiology IRG [PSE] > Infectious, Reproductive, Asthma and Pulmonary Conditions Study Section [IRAP]

Infectious, Reproductive, Asthma and Pulmonary Conditions Study Section [IRAP]

The Infectious, Reproductive, Asthma and Pulmonary Conditions (IRAP) Study Section reviews applications concerned with the epidemiology of infectious diseases, reproductive health, asthma and pulmonary conditions in human populations. Infectious diseases considered include vaccine-preventable diseases, emerging infections, respiratory infections, tuberculosis, gastrointestinal diseases caused by pathogenic microbial agents, sexually transmitted infectious diseases (excluding HIV), malaria and tropical diseases, and other diseases related to communicable agents. Reproductive health conditions considered include those related to the reproductive system, pregnancy and birth outcomes, contraception, infertility, and fetal and infant development (including birth defects and diseases of early childhood, particularly those related to reproductive health, genetics, and maternal exposures). Non-malignant pulmonary conditions considered include asthma, chronic obstructive pulmonary disease and conditions related to lung function, and other respiratory conditions. IRAP also reviews allergy and inflammatory response to infectious agents or airborne particles or accompanying reproductive conditions.



  • The distribution of diseases/conditions with respect to personal characteristics, place, and time
  • Observation studies of the determinants, predictors and biomarkers of diseases and conditions. The focus is to determine whether risk of a disease/condition is different among individuals who are exposed or not exposed to a specific factor (or combination of factors) of interest. These may be either risk or protective factors and include genetic, epigenetic, molecular, environmental, pharmacological, behavioral, and social factors.
  • Environmental exposures on reproduction, maternal health, prenatal/perinatal/neonatal health, asthma and lung conditions, and allergy
  • The transmission of infectious agents and diseases, including through animal and insect vectors, and large population studies to examine microbiome.
  • Primary prevention including those evaluated by clinical trial.
  • Research designs and methodologies to address epidemiologic questions including cohort; case-control; prospective; longitudinal; retrospective; clinical trial; cross-sectional; surveillance; genetics; genome wide association studies (GWAS); epigenetics; gene-environment interactions; and molecular genetics.

Closely Related